Keying Ma

Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study

Matthew J. Loza, Ratko Djukanović, Kian Fan Chung et al. · Respiratory Research · 2016 · 138 citations · Full text

Medicine, Biostatistics, Clinical Epidemiology +14

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Matteo Cesaroni, Loqmane Seridi, Matthew J. Loza et al. · Arthritis & Rheumatology · 2020 · 27 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study

Peter C. Taylor, Georg Schett, T. Huizinga et al. · RMD Open · 2024 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial

Ghaith Noaiseh, Kathy L. Sivils, Kim Campbell et al. · The Lancet · 2025 · 16 citations · Full text

Life Sciences, Immunology, Internal Medicine +17